Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
about
Mephedrone and nicotine: oxidative stress and behavioral interactions in animal modelsBlockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculationsAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionSerotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokersMouse models for studying genetic influences on factors determining smoking cessation success in humans.Unusual effects of nicotine as a psychostimulant on ambulatory activity in miceLack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.Nicotinic receptor gene CHRNA4 interacts with processing load in attentionThe nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancerAtypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptorsThe α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophreniaRole of the central cholinergic system in the therapeutics of schizophrenia.Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane sitePotentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.Alzheimer's disease and age-related memory decline (preclinical)Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapyPharmacological treatment effects on eye movement controlNeural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferoneSmoking status as a potential confound in the BOLD response of patients with schizophrenia.Serotonergic mechanisms in addiction-related memoriesAllosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPESDiverse actions and target-site selectivity of neonicotinoids: structural insightsPrefrontal neuromodulation by nicotinic receptors for cognitive processes.An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.Stress degradation studies on varenicline tartrate and development of a validated stability-indicating HPLC method.Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA4.The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release.Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice.The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and nicotine dependence in schizophrenia patients.
P2860
Q28393490-F66E2251-62CB-4E0C-B753-F0D1F569D412Q28477330-374A2893-54D1-4C02-9455-24A830E263FCQ30386608-B3BCC338-2A2C-4238-B369-9BDE1A6A324BQ30413322-E38638E6-7115-468B-81B3-80A0814AE57FQ30432964-A30ACD75-41A2-443C-B494-EEA43A0B22BCQ30468347-05BCFB49-F413-4E7A-8C74-37275B250142Q30487876-971557ED-4EA6-4230-9EF5-261F94B1CC4AQ33751420-DA585359-198A-4240-AE35-D29618CB3442Q33784782-0A76037E-B6DF-4ADC-84D2-DB85F0F51649Q34126960-1FADCAC4-7B43-499B-9B11-B1414DB3B5E6Q34394895-77380EB4-72AA-45B0-80CD-DDAEDA753835Q34531316-A99B161E-E1EB-430B-9A2E-6C000D8D8748Q34604413-E1F4C8EA-B917-49D4-AFE3-6F71A54BEAA2Q34608625-E70F30B5-0C7B-4C17-8B1D-16182FE354CFQ34804573-21F7BABF-D50C-4B31-BB34-7BB332EB9539Q34827173-C9CD3512-10F6-4A70-BFC1-37F2062E07AAQ35041190-82FF9750-7573-4DA7-8BE9-F1BA8CB308FBQ35048154-26ED8476-6224-4D68-95CB-DBAB26AEF65FQ35092839-166B1E73-E278-449C-B81A-12B789C9234BQ35173870-D048CEDD-FD1C-4401-AB66-0AA0621BAFA1Q35566709-DD3B6DC5-5147-438F-B764-8F76DE1D8E25Q35837691-8A14CED0-8F43-486A-A278-F6D0908D73CDQ35975080-AFD0CAD3-5279-4B2A-A7AD-B999669D7368Q36918424-6FAA859B-8CCA-4254-84CA-AE0A49363EB0Q36959123-68EA3C4E-A104-4F7E-ADCA-7B0A00C6D0FDQ37071408-8ED8181F-20B4-4C4D-B2D1-7C9ED3A80A08Q37117186-B5493135-344C-405E-A0FD-3A8F00C3F0D0Q37423563-C8A62F63-72A7-4A5A-88B2-9BD48B7F7FDAQ37976289-F2586776-0EF9-4FE0-A056-30F2A9FBBF77Q38711758-ABAAF0C5-74B5-468F-A283-EA89CA0482C0Q40271784-7AD0E77C-1887-4A6B-9B48-61807ABBC750Q41919001-869FD7DE-48FB-458B-BD6A-4145CC14E089Q42580171-40360D7E-68B0-4D73-9ACD-3186E228814AQ42606579-35062BB7-4855-4818-9738-8407956BE2E8Q42829690-E2E29B3B-C641-454E-8F4C-1D9AD2764647Q43267084-911D3F74-ECC6-44E8-8DA6-5697173A0210Q46082663-06F6879F-3571-4263-98B0-69F62EF5D47EQ46314942-352CE373-813B-484A-9BA4-BCA25780D5BCQ47819976-EB72A124-8CD7-46AD-9CF6-63421F781CD5Q47906518-C857BD46-E589-4F8B-B402-1F8B3406F91A
P2860
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nicotinic interactions with an ...... impacts on cognitive function.
@en
type
label
Nicotinic interactions with an ...... impacts on cognitive function.
@en
prefLabel
Nicotinic interactions with an ...... impacts on cognitive function.
@en
P2860
P1476
Nicotinic interactions with an ...... impacts on cognitive function.
@en
P2093
Amir H Rezvani
Edward D Levin
P2860
P304
P356
10.1016/J.BCP.2007.07.019
P407
P577
2007-07-20T00:00:00Z